Vyne Therapeutics (VYNE) has had the highest return between August 19, 2025 and August 18, 2026 by a US stock, returning 801,215.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vyne Therapeutics (VYNE) | 8/19/2025 - 8/18/2026 | 801,215.79% |
Aptorum Group Ltd Class A (APM) | 8/19/2025 - 8/18/2026 | 646,823.08% |
WhiteHawk Minerals (WHK) | 8/19/2025 - 8/18/2026 | 435,400% |
SharonAI Holdings, Inc Class A Common Stock (SHAZ) | 8/19/2025 - 8/18/2026 | 384,400% |
Seaport Therapeutics, Inc Common Stock (SPTX) | 8/19/2025 - 8/18/2026 | 243,900% |
AXT (AXTI) | 8/19/2025 - 8/18/2026 | 4,470% |
Sandisk (SNDK) | 8/19/2025 - 8/18/2026 | 3,765.13% |
Mega Fortune Company Limited Ordinary Shares (MGRT) | 8/19/2025 - 8/18/2026 | 2,976.92% |
CBL International Limited Ordinary Shares (BANL) | 8/19/2025 - 8/18/2026 | 1,445.24% |
Erasca (ERAS) | 8/19/2025 - 8/18/2026 | 1,102.63% |
Check-Cap (MBAI) | 8/19/2025 - 8/18/2026 | 1,097.37% |
New Era Energy & Digital (NUAI) | 8/19/2025 - 8/18/2026 | 1,092.14% |
Alto Neuroscience (ANRO) | 8/19/2025 - 8/18/2026 | 879.59% |
Damora Therapeutics (DMRA) | 8/19/2025 - 8/18/2026 | 847.87% |
Micron Technology (MU) | 8/19/2025 - 8/18/2026 | 724.28% |
Lumentum (LITE) | 8/19/2025 - 8/18/2026 | 723.89% |
Praxis Precision Medicines (PRAX) | 8/19/2025 - 8/18/2026 | 715.73% |
Q32 Bio (QTTB) | 8/19/2025 - 8/18/2026 | 701.51% |
Climb Bio (CLYM) | 8/19/2025 - 8/18/2026 | 685.59% |
Aehr Test Systems (AEHR) | 8/19/2025 - 8/18/2026 | 653.67% |
Sellas Life Sciences (SLS) | 8/19/2025 - 8/18/2026 | 647.13% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 8/19/2025 - 8/18/2026 | 641.11% |
Oruka Therapeutics (ORKA) | 8/19/2025 - 8/18/2026 | 640.7% |
Shattuck Labs (STTK) | 8/19/2025 - 8/18/2026 | 631.68% |
Relmada Therapeutics (RLMD) | 8/19/2025 - 8/18/2026 | 611.94% |